ARCHIVES

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

This article is from The Cancer Letter archive.

Vol. 38 No. 14 | April 6, 2012

Download PDF Visit The Full Archive

Related Articles

Hearing Probes CDC On Cancer Treatment For Working Poor In Screening Program

July 23, 1999

Cancer Control: Incidence, Death Rates Continue To Fall, Annual Reports Says

April 23, 1999

Agency Approves Two Pairs Of Drugs and Diagnostic Tests

September 30, 2011

FDA: Silicone Breast Implants Safe, But Not “Lifetime Device”

June 24, 2011

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

August 2, 1996

University Fires Bezwoda For Scientific Misconduct.

March 17, 2000